Eloxx Pharmaceuticals, Inc. (ELOX) — Net Asset Quality Index
Eloxx Pharmaceuticals, Inc. (ELOX) has a Net Asset Quality Index of 73.2% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $63.39 Million minus total liabilities of $16.97 Million yields net assets of $46.42 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read ELOX total liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Eloxx Pharmaceuticals, Inc. Net Asset Quality Index Over Time (2022–2025)
This chart shows how Eloxx Pharmaceuticals, Inc.'s Net Asset Quality Index has evolved across 4 annual periods from 2022 to 2025. As of June 2026, the index stands at 73.2%, representing net assets of $46.42 Million against total assets of $63.39 Million USD. For live market cap and overall valuation, see Eloxx Pharmaceuticals, Inc. (ELOX) total market value.
Annual Net Asset Quality Index for Eloxx Pharmaceuticals, Inc. (2022–2025)
The table below presents the year-by-year Net Asset Quality Index for Eloxx Pharmaceuticals, Inc. from 2022 to 2025, covering 4 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. See ELOX total equity for net asset value and shareholders' equity analysis.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | -225.9% | $-11.91 Million | $5.27 Million | $17.18 Million | ▲ +591.8 pp |
| 2024 | -817.7% | $-24.34 Million | $2.98 Million | $27.31 Million | ▲ +502.3 pp |
| 2023 | -1320.0% | $-22.60 Million | $1.71 Million | $24.31 Million | ▼ -1269.6 pp |
| 2022 | -50.5% | $-10.66 Million | $21.12 Million | $31.78 Million | — |